Multi-drug-resistant tuberculosis cost-effectiveness of therapy

Revision as of 20:22, 26 September 2014 by Alejandro Lemor (talk | contribs)
Jump to navigation Jump to search

Multi-drug-resistant tuberculosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multi-drug-resistant tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multi-drug-resistant tuberculosis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multi-drug-resistant tuberculosis cost-effectiveness of therapy

CDC on Multi-drug-resistant tuberculosis cost-effectiveness of therapy

Multi-drug-resistant tuberculosis cost-effectiveness of therapy in the news

Blogs on Multi-drug-resistant tuberculosis cost-effectiveness of therapy

Directions to Hospitals Treating Multi-drug-resistant tuberculosis

Risk calculators and risk factors for Multi-drug-resistant tuberculosis cost-effectiveness of therapy

Overview

Cost-effectiveness of therapy

Image obtained from CDC([1])

References

Template:WH Template:WS